Neurology Chair

Dane Chetkovich, M.D., Ph.D., Professor and Chairman
of Neurology

Faculty By Divisions

David Uskavitch, M.D.

Assistant Professor of Neurology


Dr. Uskavitch earned his B.A. degree (with distinction) from the University of Virginia College of Arts and Sciences in 1980 and his M.A.T. degree in Biology from the University of Virginia Graduate School of Arts and Sciences in 1981. He received his medical degree from the University of Virginia School of Medicine in 1987. He completed his internship in medicine at the Massachusetts General Hospital in 1988. He completed his residency in neurology at the Massachusetts General Hospital in 1991. Dr. Uskavitch began private practice in neurology with Neurologic Consultants at St. Thomas Hospital, Nashville, Tennessee in 1991. Dr. Uskavitch served as president of Neurologic Consultants from 1997-2007. He joined the Department of Neurology at Vanderbilt and moved his practice to The Vanderbilt Clinic in February of 2007.

Dr. Uskavitch currently serves as Director of the Division of General Neurology as well as Clinical Director of the Neurology Clinic, The Vanderbilt Clinic. He is board certified in Neurology. His clinical interest is in the practice of general neurology with special interest in the treatment of multiple sclerosis and migraine.


Dr. Uskavitch has participated in many clinical trials in the treatment of stroke and multiple sclerosis. His publications include:


PROACT investigators, Intra-arterial prourokinase for acute ischemic stroke (PROACT II). JAMA 1999; 282:2003-2011.

Sacco, RL et al, Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001; 285:1719-1728.

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. NEJM 2006; 355:549-559.


Department of Neurology
1161 21st Avenue South
Nashville, Tennessee 37232
Phone: (615) 936 0060
FAX (615) 343-4201